Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Germain

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Biochemical and Biophysical Research Communications|April 20, 1999
Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatchesD P Germain, L Poenaru
Clinical Genetics|January 10, 2003
Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patientsM Senechal, D P Germain
La Revue De Medecine Interne|April 29, 2006
Phenotype variations in Gaucher diseaseP Mistry, D P Germain
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 27, 2014
[Genetic aspects of mucopolysaccharidoses]D Lacombe, D P Germain
La Revue De Medecine Interne|January 30, 2008
[Therapeutic objectives in Gaucher disease]P Mistry, D P Germain
Human Mutation|January 4, 2001
Identification of novel polymorphisms in the pM5 and MRP1 (ABCC1) genes at locus 16p13.1 and exclusion of both genes as responsible for pseudoxanthoma elasticumJ Perdu, D P Germain
Acta Paediatrica (Oslo, Norway : 1992). Supplement|February 8, 2003
Endothelial markers and homocysteine in patients with classic Fabry diseaseK Demuth, D P Germain
La Revue De Medecine Interne|April 29, 2006
Therapeutic goals in Gaucher diseaseP Mistry, D P Germain
Archives of Pediatrics & Adolescent Medicine|January 1, 1997
Pathological case of the month. Pseudoxanthoma elasticumD P Germain, F M Pope
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2009
Pharmacological chaperone therapy by active-site-specific chaperones in Fabry disease: in vitro and preclinical studiesD P Germain, J-Q Fan
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|April 20, 1999
Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatchesD P Germain, L Poenaru
Clinical Genetics|January 10, 2003
Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patientsM Senechal, D P Germain
La Revue De Medecine Interne|April 29, 2006
Phenotype variations in Gaucher diseaseP Mistry, D P Germain
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 27, 2014
[Genetic aspects of mucopolysaccharidoses]D Lacombe, D P Germain
La Revue De Medecine Interne|January 30, 2008
[Therapeutic objectives in Gaucher disease]P Mistry, D P Germain
Human Mutation|January 4, 2001
Identification of novel polymorphisms in the pM5 and MRP1 (ABCC1) genes at locus 16p13.1 and exclusion of both genes as responsible for pseudoxanthoma elasticumJ Perdu, D P Germain
Acta Paediatrica (Oslo, Norway : 1992). Supplement|February 8, 2003
Endothelial markers and homocysteine in patients with classic Fabry diseaseK Demuth, D P Germain
La Revue De Medecine Interne|April 29, 2006
Therapeutic goals in Gaucher diseaseP Mistry, D P Germain
Archives of Pediatrics & Adolescent Medicine|January 1, 1997
Pathological case of the month. Pseudoxanthoma elasticumD P Germain, F M Pope
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2009
Pharmacological chaperone therapy by active-site-specific chaperones in Fabry disease: in vitro and preclinical studiesD P Germain, J-Q Fan
Pageof 5